2012年，山东科技大学法学专业，学士学位；
2015年，吉林大学法学理论专业，硕士学位；
2020年，中国政法大学法治文化专业，博士学位；
2020-2022年，中国科学院动物研究所，博士后；
2022年，beat365官方网站，助理教授
B.S. 2012, Shandong University of Science and Technology, Jurisprudence;
M.S. 2015, Jilin University, Jurisprudence;
Ph.D. 2020, China University of Political Science and Law University, Jurisprudence;
Postdoctoral Fellow, Institute of Zoology, Chinese Academy of Sciences, 2020-2022;
Assistant Professor, School of Life Sciences, Xiamen University, 2022

生物技术法律与伦理，生物技术治理，生物技术知识产权
Biotechnology Law and ethics, biotechnology governance, biotechnology intellectual property

代表性论文(^# co-first author, ^* Corresponding author):

1. Zhenyu Xiao^#, Jianwei Lv^#, Siqi Zhao, Rosario Isasi, Xinwei Xie, Lei Dong, Yaojin Peng^*, The Potential Effects of the United States Abortion Ruling on Global Embryo/Foetal and Stem Cell Research, Life Medicine, 2022(Accepted).
2. Yaojin Peng^#*, Jianwei Lv^#, Lulu Ding, Xia Gong, Qi Zhou^*, Responsible Governance of Human Germline Genome Editing in China, Biology of Reproduction, 2022, ioac114. .
3. Yaojin Peng^#*, Jianwei Lv#, Zhenyu Xiao, Lulu Ding, Qi Zhou^*, A framework for the responsible reform of the 14-day rule in human embryo research, Protein & Cell, published online: 15 Feb. 2022.
4. Jianwei Lv^#, Yeyang Su^#, Lingqiao Song, Xia Gong, Yaojin Peng^*, (2020), Stem cell ‘therapy’ advertisements in China: infodemic, regulations and recommendations, Cell Prolif, e12937, doi: 10.1111/cpr.12937, Epub ahead of print.
5. 彭耀进，吕建伟. 人类胚胎研究14天规则的挑战与出路. 自然辩证法通讯2022,44(10): 77-86.
6. 吕建伟，彭耀进. 人体生物样本知情同意退出制度重塑. 科学与社会. 2022,12(02): 137-156.
7. 吕建伟. 知识产权确认不侵权之诉的受理条件. 人民论坛. 2019, (11):89-91.

荣誉、奖励及参加学术团体的情况: